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ABSTRACT
￿
Human WI-38 fibroblasts in cultures synthesized at least three molecular forms of
the major, extracellular matrix glycoprotein (GP), GP140 : (a) cytoplasmic GP140 (1 .2 ng of
GPl40/pg of cell protein) was detergent-soluble, underglycosylated, and possessed detectable
levels of intermolecular disulfide bonding; (b) matrix GP140 (3.6 ng of GP140/Ag of cell
protein) was detergent-insoluble, more highly glycosylated and polymerized by intermolecular
disulfide bonding, and co-distributed in the extracellular matrix with fibronectin ; and (c)
released GP140 (2 ng of GP140/Ag of cell protein per 24 h) was recovered in the conditioned
culture media and lacked intermolecular disulfide bonding. Cytoplasmic GP140 was the
immediate biosynthetic precursor of the matrix form of GP140 . In addition, various human
adult and fetal tissues contained a form of GP140 that resembled the fibroblast matrix GP140
in the degree of intermolecular disulfide bonding, relative molecular mass, and immunological
reactivity. Analysis of the sequence of events in assembly of GP140 and fibronectin in the
extracellular matrix detected the following: (a) fibronectin was first to appear in the extracellular
matrix; (b) GP140 accumulated in the cytoplasm, then deposited in the extracellular matrix
and co-aligned with the established fibronectin; and (c) maturation of the extracellular matrix
proceeded by continued intermolecular disulfide bonding. To evaluate possible roles for
intermolecular disulfide bonding in cell interactions, a unique assay system was utilized based
on the ability of labeled cells to incorporate radioactive matrix components into a biotinylated
exogenous matrix. Precipitation of the biotinylated matrix from extracts of the cultures using
avidin indicated : (a) disulfide bonding of radioactive GP140 and fibronectin into the exogenous
biotinylated matrix required cell contact with the matrix. The newly deposited GP140 and
fibronectin derived from the cells and not from GP140 and fibronectin present in the
conditioned culture media. (b) Pro-a1 and Pro-a2 procollagens, present in the culture media,
bound to the exogenous matrix in a noncovalent manner and were independent of cell
contact. (c) SV40 transformed cells (WI-38 VA13) synthesized released form GP140 but did
not deposit GP140 into the biotinylated matrix.
The extracellular matrix of cultured human fibroblasts has
been reported to contain fibronectin (1-10), procollagens, (2,
4, 7), chondroitin sulfate (5), and heparan sulfate (5). Two
additional cell surface-labeled glycoproteins (GPs),' GP250
and GP140, have also been described as components of the
'Abbreviations used in thispaper: BNS, 50 mM sodium borate buffer,
pH 7.8, containing25 mM NaCl and 1 mM EDTA; DME, Dulbecco's
modified Eagle's medium; GP, glycoprotein; NEM, N-ethylmaleim-
ide.
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detergent-insoluble matrix of WI-38 fibroblasts (8-10).
GP250 and GP140, like fibronectin, were absent from the
extracellular matrix of SV40 transformants of WI-38 cells
(WI-38 VA13 cells) and the human fibrosarcoma cell line
HT-1080 (10). However, both normal and transformed cells
accumulated these glycoproteins in their conditioned media
(10).
The quantities of GP140 and fibronectin in the matrix of
normal fibroblasts were elevated with increasing cell density
and time in culture (8). The matrix fibronectin and GP140
105were both resistant to solubilization with nonionic and dipolar
ionic detergents and urea. Similarly, both glycoproteins were
readily solubilized with chaotropic agents but only in the
presence of reducing agents.
Characterization of GP140 (8-10) indicated the following:
(a) isolated multimeric GP140, but not reduced monomeric
GP140, induced stable cell attachment. (b) Matrix GP140
contained both hydroxyproline and hydroxylysine residues,
suggesting that it was a collagenlike glycoprotein. A compar-
ison of GP140 with collagen types I-VI utilizing both im-
munological and biochemical techniques has indicated that
GP 140 is related to type VI collagen (11). In tissue, the native
form of GP140 is a precursor to subunits ofpepsin-generated
type VI collagen. (c) In ligand-blot assays and affinity chro-
matography, pro-al and pro-a2 and GP140 were found to
associate with fibronectin, suggesting interactions on the cell
surface either directly or indirectly. (d) GP140 in the extra-
cellular matrix, like fibronectin and GP250, possessed exten-
sive intermoleculardisulfide bonds, resulting in the formation
of multimers of high molecular mass. Published results sug-
gested that GP140 formed homomultimers that did not in-
volve intermolecular disulfide bonding of GP140 with other
matrix glycoproteins such as fibronectin (8, 9).
The study reported here describes: (a) multiple forms of
GP140 present in the cytoplasm, matrix, and conditioned
media of cultured cells and in tissue; (b) the localization and
sequence of deposition of GP140 and fibronectin in the
extracellular matrix; (c) the degree ofintermolecular disulfide-
dependent polymerization of the various forms of GP140 in
normal and transformed cells; and (d) the possible role of
intermolecular disulfide bonding in modulating the assembly
of the extracellular matrix.
MATERIALS AND METHODS
Materials
Dithiothreitol, phenylmethylsulfonyl fluoride, paraformaldehyde, N-ethyl-
maleimide(NEM), rabbit -y-globulin, Lens culinarislectin, BSA, Triton X-100,
EDTA, avidin, and adenosine triphosphate were purchased from Sigma Chem-
ical Co., (St. Louis, MO). SDS, nitrocellulose sheets, and molecular mass
standards were from Bio-Rad Laboratories (Richmond, CA). Protein A and
Sepharose were from Pharmacia Fine Chemicals (Piscataway, NJ).. 2-Mercap-
toethanol and N-hydroxysuccinimidobiotin were from Pierce Chemical Co.
(Rockford, IL). Empigen BB, a dipolar ionic detergent, was a generous gift
from Albright &Wilson (Whitehaven, England). Rhodamine-conjugated (goat)
anti-rabbit IgG (heavyandlight chains) and fluorescein-conjugated (goat) anti-
mouse IgG (heavy andlight chains) were from Bionetics Laboratory Products
(Kensington, MD). IgG sorb (Staphylococcus aureus) was from TheEnzyme
Center (Boston, MA).
Cells and Cell Culture
Normal embryonic human lung diploid fibroblasts, WI-38, and SV-40
transformants of these cells, WI-38 VA13, were obtained from the American
Type Culture Collection. A human rhabdomyosarcoma cell line, A204, and a
human astrocytoma cell line, 251 MG, were obtained from Dr. Kari Alitalo,
Department of Microbiology andImmunology, University of California, San
Francisco, CA. Cells were grown in Dulbecco's modified Eagle's (DME) me-
dium and 10% fetal bovine serum in a 5% CO, atmosphere.
Preparation of Matrix and Empigen BB-
soluble Extract
Matrix was prepared from cultured cells grown on tissue culture plates as
follows: the conditioned culture medium was removed and aminimal volume
(-2 ml/15-cm plate ofcells) of2% vol/vol Empigen BB and 0.1% wt/vol SDS
in 50 mM sodium borate buffer, pH 7.8, containing 25 mM NaCI, 1 mM
106
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EDTA (referred to as BNSbuffer), 1 mM phenylmethylsulfonyl fluoride, and
2 mM NEMwere added. Theadherent matrix andthe detergent were scraped
from the plate with a rubber policeman and the suspension was centrifuged at
35,000 g for 15 min. The pellet was termed "Empigen BB-insoluble matrix,"
andthe supernate, "Empigen BB-soluble extract."
Preparation of Antisera
ANTISERA TO GP140 AND FIBRONECTIN: Antisera to GPI40 and
fibronectin wereprepared in rabbitsandaffinity purifiedas previously described
(9,10).
MONOCLONAL ANTIBODY TO FIBRONECTIN : The monoclonal an-
tibody (D-5 preparation, 12) was prepared and donated by Mark Patterson and
Dr. Kiyo Sekiguchi.
Polyacrylamide Gel Electrophoresis
Polyacrylamide slab gels containing 0.1% SDSwere prepared following the
basic stacking SDS-gel technique of Laemmli (13). Samples were dissolved in
a sample buffercontaining 2%wt/vol SDS, 5°% vol/vol 2-mercaptoethanol and
heated in a boiling water bath for 5 min. Slab gels were stainedwith Coomassie
Blue R-250 or silver stain (from Bio-Rad Laboratories). Fluorography ofslab
gels followed the procedure ofBonner andLaskey (14). Protein standards for
relative molecular mass estimation in polyacrylamide gels were as follows:
ovalbumin, 45,000; BSA, 66,200; phosphorylase b, 92,500; ß-galactosidase,
116,250; myosin, 200,000. Standards were from Bio-Rad Laboratories. Protein
was determined by the fluorescamine method (15).
Electrophoretic Blotting and Reaction with
Antibodies and Lectins
After completion of the electrophoresis, the proteins were transferred to
sheets of nitrocellulose using a modified version ofthe procedure described by
Towbin et al. (16). Reaction with antibodies and "'I-protein A and autora-
diography were as previously described (11). Protein standards were labeled
with "'I for relative molecular mass estimation on the autoradiograms and for
making comparisons ofmultiple autoradiograms. Reaction with I"'fl-labeled
lentil lectin or avidin after electrophoretic transfer, followed the previously
described lectin blotting procedure (11). Protein A, lectins, andmolecular mass
standards were iodinated utilizing the chloromine T method (17). Avidin was
labeled with 'nI-Bollen-Hunter reagent (18).
In the results presented in Fig. 6 (q.v.), the transfer of the polymeric forms
of GP140 to nitrocellulose for immunoblotting was inefficient under nonred-
ucing conditions. In order to increase the efficiency oftransfer, samples to be
analyzed under nonreducing conditions were; first, run under nonreducing
conditions then reducing sample buffer was applied to the top of the gels 30
minbefore termination of the electrophoresis.
Cell Density-dependent Alterations in GP140
and Fibronectin
Thequantities ofGP140 and fibronectin present in the Empigen BB soluble
and insoluble extracts and conditioned culture media were assayed as follows:
WI-38 cells were passaged with trypsin/EDTA/phosphate-buffered saline (500
,ug/ml, 10 mM at 37° for 15 min) under conditions known to remove cell
surface fibronectin and GP140. The cells were washed two times with DME
medium containing 10°ío vol/vol fetal bovine serum that had been depleted of
fibronectin by passage over gelatin-Sepharose (19). The cells were then plated
on 15-cm culture dishes (2 x 10' cells/plate) and cultured for the indicated
timeperiods(see Fig. 2). Media was changedon all platesevery 3 d. 24 hbefore
each time point, two plates were washed three times with DME and were
continued in culture with 15 ml ofDME. The next day, the conditioned DME
was pooled, adjusted to a final concentration of 1 mM phenylmethylsulfonyl
fluoride, 5 mM EDTA, and 2 mM NEM, and centrifuged at 35,000 gfor 15
min. The supernatants were saved for analysis of released-form matrix com-
ponents.
One plate ofcells from each time point was utilized for quantitation ofcell
number, after suspension with trypsin, by counting with a Coulter Counter
(Coulter Electronics, Inc., Hialeah, FL). Theremaining plate was extracted as
describedunder the subsection "Preparation ofMatrix and Empigen BB-soluble
Extract."
Aliquots of each extract, derived from 25 #g of total cell protein, were
fractionated bypolyacrylamide gel electrophoresis, transferredto nitrocellulose,
and reacted with antibody and "'I-protein Aas described below.Quantitation of Antibody Binding to GP140
and Fibronectin
Afterautoradiography of the labeled nitrocellulose sheets to locate radioac-
tive spots, the spots were excised along with negative control spots of the same
size, and counted in a -y-counter. Standard samples ofpurified GP140 (9) and
W138 released form fibronectin (protein range of 0.01-1 ug) were utilized as
protein standards for quantitation ofradioactivity bound to unknowns. Stand-
ards and unknowns were always analyzed on the same gel to avoid variation
in transfer efficiency to nitrocellulose.
Pulse-Chase Experiments and
Immune Precipitation
Identical plates (6.0-cm diam) ofW 138 cells were grown to confluence and
then metabolically labeled with radioactive methionine (100 pCi ["S]methio-
nine for 2 h) . At time 0, the labeling medium was removed and the plates were
washed three times with completeDME medium containing 10% vol/vol fetal
bovine serum followed by incubation in the same media . At 2, 4, 18, 46, and
72 h after time 0, the media was removed from a plate, the plate was washed
three times with phosphate-buffered saline and the cells were suspended in 1
ml ofEmpigen BB in BNS buffer as described above in "PreparationofMatrix."
The Empigen BB-soluble extract was collected by centrifugation and the
Empigen BB-insoluble matrix was suspended in 1 ml of0.5% wt/vol SDS in
25 mM sodium borate, pH 7.8, plus 1 mM EDTA + 2 mM NEM and 1 mM
phenylmethylsulfonyl fluoride and heated to 100°C for 5 min .
Before immune precipitation, aliquots (100 tul) of each extract were incu-
bated at 100'C for 5 min with and without 0.05% vol/vol 2-mercaptoethanol .
Immune precipitation was as previously described (8) . In control experiments
the amount ofantibody required to precipitate all GP140 had been determined .
Where indicated, as in Figs. 4 and 7 the immune precipitated proteins were:
(a) detected on gels by fluorography, (b) quantitated by excision from the gel
and dissolution in H202/perchloric acid (20) and counted in a liquid scintilla-
tion counter or (c) transferred to nitrocellulose and examined by the immu-
noblot technique.
Disulfide Bonding of GP140 to Biotinylated
Exogenous Matrix
WI-38 cells were grown to confluence on two cell culture plates of 15-cm
diam (See Fig. 8). The culture plate had a glass divider (1 .5 mm high) fixed to
the bottom ofthe culture surface forming two halves on each plate . Both plates
were then extracted with Empigen BB to prepare adherent monolayers of
Empigen BB-insoluble matrix . Each divider plate received 5 ml of phosphate-
buffered saline followed by 50 tal of dimethyl sulfoxide or 50 tul of dimethyl-
sulfoxide containing 5 mg of N-hydroxysuccinimidobiotin . The plates were
incubated for 15 min at room temperature with occasional agitation, then
washed four times with phosphate-buffered saline.
In parallel, WI-38 cells were metabolically labeled with ['H]glycine, washed,
trypsinized for suspension, washed again twice with culture media containing
10% vol/vol fetal bovine serum, then plated on one side only ofthe biotinylated
and nonbiotinylated divider plates.
After 3 h ofincubation to permit cell attachment, additional culture media
was added to allow free access of conditioned culture media over the barrier to
both sides of the plate . The plates were continued in culture for 2 d, then re-
extracted with Empigen BB, followed by 1 M urea in 1 M NaCI to lyse nuclei
and release nucleic acids . The presence of nucleic acids interfered with the
subsequent steps. The remaining insoluble residue on each side of the divider
was dissolved in 2 .0 ml of0.5% wt/vol SDS in 25 mM sodium borate pH 7 .8
containing 2 mM NEM by heating at 100° for 5 min . Duplicate aliquots (250
tul) ofeach extract were incubated with or without 0.5% 2-mercaptoethanol at
100° for 5 min, followed by cooling and mixing with 500 kl of BNS buffer
containing 1 % vol/vol Triton X-100 and 1% wt/vol BSA. Duplicate samples
were incubated with or without 100 kg ofavidin for 18 h on ice. The precipitates
were collected by centrifugation at 12,000 g in a microfuge and washed twice
with BNS containing 1% Triton X-100 .
RESULTS
Empigen BB-soluble and Matrix Forms of GP140
GP140 was first described as a cell surface glycoprotein
present in the Empigen BB-insoluble matrix of cultured hu-
man fibroblasts (8-10) . However, as seen in Figs . 1 and 2, the
FIGURE 1
￿
Accumulation of GP140 in cultured W138 cells . WI-38
cells were suspended by trypsin digestion and replated at high cell
density (5 x 10 6 cells/15-cm plate) . At the indicated time points (1,
3, 6, and 8 d) after replating, the cells were washed 3 times with
PBS, then extracted with Empigen BB to prepare Empigen BB
Soluble and insoluble Matrix preparations . Extracts from 75 lag of
cell protein were analyzed by polyacrylamide gel electrophoresis
in the presence of SDS (5% acrylamide) followed by electrophoretic
transfer to nitrocellulose and reaction with specific antiserum to
GP140 . GP140 in the Empigen-soluble and matrix extract migrated
as two closely spaced bands indicated by lines in the left margin .
accumulation of the insoluble form ofGP 140 coincided with .
the accumulation of an Empigen BB-soluble GP140 . The
soluble GP 140 was recovered in the supernatant after centrif-
ugation at 100,000 g for 60 min and migrated as two closely
spaced bands with slightly higher mobility than the matrix
form after electrophoresis on polyacrylamide gels (Fig . 1) .
The accumulation of the soluble and insoluble forms of
GP140 was apparent with increased cell density and pro-
longed time in culture after confluence (Fig . 2A and B),
reaching levels of 1 .2 and 3 .6 ng of GP 140 per jug of cell
protein, respectively . In contrast, only relatively small quan-
tities of soluble fibronectin (0.2-0.4 ng/,ug of cell protein)
were detected at any cell density, in agreement with a report
(21) that no large pools of detergent-soluble (cytoplasmic)
fibronectin accumulated in cultured fibroblasts . The majority
ofcell-associated fibronectin was detected as an Empigen BB-
insoluble matrix (Fig. 2).
The relative quantities of the soluble and insoluble GP140
were not affected to any appreciable degree by the addition
of sodium ascorbate (50 Ag/ml) to the culture media, a
modulator of collagen hydroxylation (22) . Also, neither daily
changes of the culture media nor the addition of conditioned
culture media from old confluent cells to new confluent cells
had any effect on the accumulation of the insoluble GP140 .
RELEASED FORM : Normal fibroblasts also produced a
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FIGURE 2
￿
Quantitation of Empigen BB-soluble matrix and released
forms of GP140 in WI-38 cells. After the indicated time in culture
(days), duplicate plates were assayed for total cell number and total
cell protein. Empigen BB-soluble extracts, Empigen BB-insoluble
matrix, and the conditioned, serum-free culture media were as-
sayed for their content of GP140 and fibronectin utilizing the
immunoblot technique as described in Materials and Methods. (A)
", cell number and O, total cell protein; (8) O, cytoplasmic GP140,
A, fibronectin, ", matrix GP140, and A, fibronectin; (C) ", released
form GP140 and A, fibronectin.
released form ofGP 140 that was recovered in the conditioned
culture medium. The quantity of GP140 detected in the
conditioned culture media after 24 h of growth (Fig. 2C),
slowly increased with time in culture reaching a maximum of
-2 ng ofGP 140/ßg oftotalcell protein per 24 h. The quantity
ofreleased fibronectin recovered during the same time periods
was two to four times higher. WI-38 VA13 and HT-1080
fibrosarcoma cells synthesized the released GP140, although
in reduced quantities (10), but failed to accumulate GP140 in
the matrix. Similarly, A204 cells, a human rhabdosarcoma,
and 251 MG cells, a human astrocytoma cell line, also failed
to deposit GP140 into the matrix (results not shown), but did
synthesize and release GP140 into the conditioned medium.
TISS UE FORM:
￿
Application of the differential extraction
protocol, originally designed for isolation of GP140 from WI-
38 cells (9), to fetal human lung tissue or adult liver, lung, or
muscle tissue also partially purified a similar glycoprotein in
the urea-DTT extract. The migration of the tissue form of
GP140 was similar to WI-38 cell matrix GP140 on polyacryl-
amide gels and reaction with antibodies prepared against
GP140 from WI-38 cell matrix (results not shown). In con-
trast, GP140 was not detected in human demineralized bone
collagenous matrix or human plasma.
CYTOPLASMIC PRECURSOR OF MATRIX FORM : The
Empigen BB-soluble and insoluble matrix GP140 were both
resistant to digestion with trypsin (10 ug/ml for 20 min) in
the presence or absence of EDTA (5 mM). In contrast, fibro-
nectin was readily digested under either condition. Pronase
digestion (100 wg/ml for 30 min) or trypsin digestion at the
same concentration with or without EDTA removed all the
Empigen BB-insoluble GP140 and fibronectin in the matrix,
but only degraded some of the soluble GP140 in whole cells
(results not shown). These results suggested that the insoluble
form of GP 140 was located primarily at the cell surface along
with fibronectin, probably as an extracellular matrix compo-
nent as previously described (8-10). In contrast, the majority
of the Empigen BB-soluble GP140 was resistant even to
pronase, suggesting that it was cryptic, with a possible cyto-
plasmic, non-cell surface location.
The soluble and insoluble forms of GP140, exhibited small
but reproducible differences in their migration on polyacryl-
amide gels (Fig. 3). The possibility that the apparent differ-
ences in relative molecular mass may be due to differences in
the glycosylation of the two forms was examined utilizing the
lectin blotting procedure (10). Similar quantities of soluble
and insoluble GP140, as determined by quantitative immu-
noblotting, bound strikingly different quantities of labeled
lentil lectin (Fig. 3). Only the insoluble GP140 bound lentil
lectin and this binding was specifically inhibited in the pres-
ence of a-methyl mannoside.
Pulse-chase experiments clarified the precursor-product re-
lation of the soluble and insoluble GP140. As can be seen in
Fig. 4, pulse-labeled GP 140 accumulated in the Empigen BB
insoluble matrix with increasing chase time up to 18 h. The
increase in label in matrix GP140 was paralleled by a corre-
sponding decrease in label associated with the Empigen BB-
soluble GP140. The soluble and insoluble GP140 were iden-
tified by both immune precipitation and immunoblotting
with antibodies to matrix GP 140. In contrast, label in various
other matrix components, including pro-a1 and pro-a2 (pre-
viously termed GP 190 and GP170, respectively [ 10]), exhib-
ited continuous decreases during the chase period (results not
shown). Labeled fibronectin was also maximally recovered in
the matrix at 0 time and decreased during the chase period
(Fig. 4). These results indicated that Empigen BB-soluble
GP140 is a cytoplasmic, under-glycosylated precursor to the
matrix GP140.FIGURE 3 Binding of lentil
lectin to GP140. The Empigen
BB-soluble, and insoluble ma-
trix of WI-38 cells was pre-
pared and fractionated by
polyacrylamide gel (5%) elec-
trophoresis in the presence of
SDS followed by electropho-
retic transfer to nitrocellulose .
The GP140 in the two extracts
was detected by immunoblot-
ting with antiserum to GP140
and differences in glycosyla-
tion were detected by reac-
tion with [' 251]-lentil lectin . 1,
Empigen BB-soluble extract ; 2)
Empigen BB-insoluble matrix .
Co-distribution and Sequence of Deposition of
GP140 and Fibronectin in the Matrix
In newly confluent cells, in which GP140 was primarily
Empigen BB-soluble (immunoblot control not shown), anti-
bodies to GP140 were localized primarily in the cytoplasm
(Fig . 5) . In the same field of view, fibronectin was distributed
predominantly as a fibrillar, extracellular matrix component
with negligible levels in the cytoplasm agreeing with the results
presented in Fig. 2 . In addition, some of the antibodies to
GP140 were also co-localized with the fibrillar fibronectin,
but in spots or clumps along the continuous fibronectin fibers .
The co-alignment of GP140 and fibronectin was clearly evi-
dent in the Empigen BB-insoluble matrix of identical cells
that were cultured at confluence for an additional 3 d before
immunofluorescence examination . In these older cells, the
antibodies to GP140 were localized in bright spots along the
continuous fibronectin fibers .
Disulfide Bonding of Multiple Forms ofGP140
In sharp contrast to the disulfide-bonded, multimeric struc-
tures ofGP140 found in matrix, the released forms ofGP 140
from normal and transformed cells exhibited a lower degree
of polymerization (Fig . 6). Additional, small differences be-
tween the released GP 140 from normal and transformed cells
were also observed (Fig . 6) in molecular mass and degree of
polymerization . Normal released GP 140 was a mixture of
monomeric, dimeric, and polymeric GP140, whereas released
GP140 from transformed cells was primarily monomeric . At
best, <50% of the cytoplasmic GP140 was ever found to be
monomeric (see Fig . 6), and many samples analyzed were
entirely polymeric . This result, although surprising, indicated
that polymerization of GP140 may occur to a significant
degree within the cytoplasm of the cells . The degree ofpolym-
erization of the cytoplasmic GP140 must, however, be con-
siderably less than that of the matrix form to permit solubili-
zation by extraction with Empigen BB .
Multimers of Disulfide-bonded GP140
Immune precipitation ofSDS extracts of the Empigen BB
insoluble matrix, under nonreducing conditions, using anti-
bodies to GP140 precipitated a major band that comigrated
withGP140 and was also reactive with anti-GP140 antibodies
via immunoblot assay . In addition, a relatively minor labeled
component that migrated in the region ofGP250 or fibronec-
tin was also immune precipitated . This higher molecular
weight component did not react with anti-GP140 antibodies
by immunoblot assay (Fig. 7) suggesting that it was antigeni-
cally unrelated to GP140 despite the co-precipitation . Reduc-
tion of the SDS extract before immune precipitation elimi-
nated the higher molecular weight component .
Disulfide Bonding of GP140 to Exogenous Matrix
The possibility that newly deposited GP140 may disulfide-
bond to matrix in adjacent cells or exogenous matrix, as a
N4 25
Z1
0
ó
10
Z
35
12
~1 a
Z Z
O
U
0
10 20 30 40
CHASE PERIOD
CHASE PERIOD
40
A
FIGURE 4 Quantitation of pulse-chase labeled GP140 and fibro-
nectin . WI-38 cells were pulse-labeled with [ ssS]methionine for 2
h then chased for the indicated times . Empigen BB-soluble extracts
and insoluble matrix were prepared at each time point in the chase
period and subsequently immune precipitated with specific anti-
bodies to either GP140 or fibronectin . The precipitates were frac-
tionated on polyacrylamide gels and the radioactive GP140 and
fibronectin bands were quantitated . (A) O, matrix GP140 and ",
Empigen BB-soluble GP140; (8) 0, matrix fibronectin and " , cyto-
plasmic fibronectin .
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109FIGURE 5 Localization of GP140 and fibronectin in cultured WI-38 cells utilizing immunofluorescence microscopy . Newly
confluent cultures of WI-38 cells (confluent for 1 d), in which most of the cellular GP140 was Empigen BB-soluble, were examined
after methanol fixation . Old confluent cultures of WI-38 cells (confluent for 4 d), in which most of the cellular GP140 was Empigen
BB-insoluble, were examined after extraction with Empigen BB and methanol fixation . Affinity-purified (rabbit) anti-human GP140
antibodies were detected with rhodamine-conjugated (goat) anti-rabbit igG antibodies . Mouse monoclonal antibodies to human
fibronectin were detected with fluorescein-conjugated (goat) anti-mouse IgG antibodies . In control experiments, nonimmune
antibodies stained with both of the fluorescent second antibodies produced negligible background . Nonimmune antibody
controls were photographed and printed with the same exposure settings as the immune antibody preparations. (1 and 2) Same
field ; whole, new confluent cells ; 1, anti-GP140; 2, antifibronectin ; (3 and 4) Same field ; matrix, old confluent cells; 3, anti-GP140 ;
4, antifibronectin; (5 and 6) Same field ; matrix, old confluent cells ; 5, control for rhodamine ; 6, control for FITC . x 400 .
means of stabilizing intercellular interactions was examined
in Fig. 8 . The protocol examined the ability of labeled cells
to incorporate radioactive matrix components into an exog-
enous matrix that had been derivatized with biotin .
Biotinylated or nonbiotinylated matrix, when incubated
with conditioned media but without cells, bound only two
0
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minor labeled proteins and these co-migrated with pro-al,
and pro-a2 procollagen . In contrast, when either biotinylated
or nonbiotinylated matrix was incubated in the presence of
cells and conditioned media, a number of labeled proteins
including a majorGP 140 band were deposited in the matrix.
Biotinylation of the matrix did not appreciably alter theFIGURE 6 (A) Disulfide bonding of cytoplasmic GP140, matrix
GP140, and released GP140 from normal and transformed cells .
Samples of various forms of GP140 were analyzed by polyacryl-
amide gel (5%) electrophoresis in the presence of SDS and 2-
mercaptoethanol for reducing conditions (+2-ME) and SDS and N-
ethylmaleimide (2 mM) for nonreducing conditions (-2-ME) fol-
lowed by immunoblotting with antiserum to GP140 . 1 Cytoplasmic
GP140 of WI-38 cells ; 2 Empigen BB-insoluble matrix from WI-38
cells ; 3 conditioned medium from WI-38 cells; 4 conditioned me-
dium from WI-38 VA13 cells .
attachment of cells to the matrix or the pattern of major
labeled proteins deposited in the matrix . In control experi-
ments (results not shown), unlabeled cells were incubated on
matrix withconditioned media from labeled cells. Under these
conditions only labeled pro-oz 1 and pro-a2 from the condi-
tioned medium were deposited in the matrix. These results
combined with the above results suggested that pro-a 1 and
pro-a2 in conditioned mediumbound to exogenous extracel-
lular matrix with or without the presence of viable cells.
Conversely, other matrix components such as GP140 and
fibronectin were deposited in the matrix, to a detectable
degree, only in the presence ofcells, with or without condition
medium .
In control experiments only biotinylated matrix coupled
radioactively labeled avidin . Various matrix components in-
cluding GP140 were derivatized with biotin during the label-
ing procedure (results not shown) . Similarly, incubation of
the extracts with avidin caused precipitation of matrix com-
ponents onlywhen the matrix was biotinylated. Furthermore,
precipitation of 'H-labeled matrix only occurred when the
biotinylated matrix had been incubated in the presence of
cells and not just conditioned media. Thus, even after solu-
bilization in SDS, radioactively labeled GP140 and possibly
some fibronectin were specifically precipitated by avidin .
These results indicated that ['H]GP 140 had covalentlybound
to the biotinylated matrix in a manner that was resistant to
disruption with hotSDS . Additional control experiments were
also performed as follows (results not shown) : (a) mixing of
SDS extracts prepared from radioactively labeled matrix and
SDS extracts ofbiotinylated matrix, followed by reaction with
avidin, precipitated only biotinylated matrix and no radioac-
tive label . Thus radioactive label is not precipitated as a result
of entrapment or artifactual cross-linking with biotinylated
matrix . (b) Avidin precipitation of either the Empigen BB
extracts or urea-NaCI extracts (see Materials and Methods)
did not precipitate any specific radioactive components . The
cross-linked components were recovered in the SDS extract
of the matrix only.
The addition of 2-mercaptoethanol to the avidin-precipi-
tation reaction completely abolished the precipitation of the
['H]GP140 but only partially inhibited the precipitation of
the biotinylated matrix components. The incorporation of
['H]GP140 to the biotinylated matrix involved intermolecular
disulfide bonding as the covalent interaction . Furthermore,
the association required the presence of cells in that condi-
tioned media had no detectable affect on deposition of either
GP 140 and/or fibronectin . Thus, labeled GP 140 that depos-
ited into the exogenous extracellular matrix was derived from
the labeled cells and not from the released form GP 140
present in conditioned media. In contrast, the ['H]pro-a 1 and
['H]pro-a2 that was deposited in the matrix originated in the
conditioned media, and their deposition did not require cell
contact with the matrix and did not involve intermolecular
disulfide bonding .
WI-38 VA13 cells did not synthesize matrix GP140 but did
synthesize released form GP140. As expected, when WI-38
VA 13 cells were metabolically labeled with ['H]glycine then
grown on biotinyl matrix from WI-38 cell as described above,
the transformed cells failed to incorporate any radioactive
GP140 into the biotinyl matrix .
FIGURE 7
￿
Immune precipitation of matrix GP140 from WI-38 cells.
WI-38 cells were metabolic labeled with [ 35S]methionine and the
Empigen BB-insoluble matrix was prepared . The matrix was solu-
bilized with SDS under nonreducing conditions, divided into equal
aliquots, and incubated in the presence or absence of 2-mercap-
toethanol (indicated as + or -2-ME) as described in Materials and
Methods. The matrix extracts (indicated as EXTRACT, ±2-ME) were
immune precipitated with or without antibodies to GP140 (labeled
+ or -ANTIBODY) and the resulting precipitates (PRECIPITATES)
were fractionated by polyacrylamide gel electrophoresis (5% gel)
and detected by fluorography or immunoblotting with antibodies
to GP140.
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Interrelation of Multiple Forms of GP140
WI-38 cells in culture produce three forms of GP140;
cytoplasmic, matrix, and released. In addition, GP140 found
in various fetal and adult human tissues appears to be similar
in molecular weight, intermolecular disulfide bonding, and
antigenic reactivity to the matrix form of GP140 from WI-38
fibroblasts. Extraction of cultured WI-38 cells with Empigen
BB solubilized the cytoplasmic GP 140 and left the matrix
GP140 in the insoluble residue. Evidence for the localization
of the Empigen BB-soluble form of GP140 in the cytoplasm
included: (a) the resistance ofthe Empigen BB soluble GP140
to pronase digestion of intact cells under conditions that
degraded the matrix form of GP140; and (b) prominent
immunofluorescence staining of the cytoplasm of newly con-
fluent cellswith subsequent removal ofthe cytoplasmic stain-
ing by extraction with Empigen BB.
Although a minor quantity of GP140 may have been
directly associated with the plasma membrane, no such local-
ization was observed by immunofluorescence microscopy.
Thus, GP140 is probably unrelated to the various calcium-
dependent cell adhesion molecules of similar molecular
weight described by others (23-28).
Characteristically, the cytoplasmic and matrix GP140 both
accumulated in the cell layer with prolonged periods of cul-
turing and existed primarily as polymeric structures. In con-
trast, the released form of GP 140 possessed very little inter-
molecular disulfide bonding. These observations suggested
that the accumulated cytoplasmic GP140 was the direct pre-
cursor of the matrix GP140. This suggestion was confirmed
by: (a) pulse-chase experiments that indicated that the accu-
mulation of GP140 in the matrix was paralleled by corre-
sponding decreases in cytoplasmic GP 140; (b) the intermolec-
ular disulfide bonding of GP140 into exogenous matrix re-
quired cell contact with the exogenous matrix and was inde-
pendent of the released form of GP140 present in the condi-
tioned media.
Released form GP 140 may be derived from a relatively
small pool of unpolymerized, cytoplasmic GP140 as seen in
the WI-38 VA 13 cells that produced only released form
GP 140. It is unlikely that the released form of GP 140 derived
from dissociation ofthe matrix GP 140. The half-life ofGP140
in the matrix (t,l, = 73 h; 9) is too long to account for the
relatively largequantities ofGP 140 present as a nondisulfide-
bonded form in the condition media (2 ng/ktg ofcell protein/
24 h). It is unclear at this time if released GP 140 represents a
biologically significant form of GP140 or if it is simply a cell
culture artifact, generated by insufficient intermolecular di-
sulfide bonding. The lack of intermolecular disulfide bonding
was most pronounced in the released form of GP140 from
transformed cells.
Interaction of GP140 and Fibronectin
The following observations have suggested that GP140 and
fibronectin may specifically interact with each other in the
extracellular matrix of cultured human fibroblasts either di-
rectly or through some intermediary component(s): (a) both
GP 140 and fibronectin were recovered in the Empigen BB-
insoluble matrix of confluent human fibroblasts along with
GP250(8-10). (b) Isolated, nonreducedGP140 induced stable
cell attachment in cell adhesion assays. However, trypsiniza-
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tion of the cell surface under conditions that released the
external fibronectin also decreased the ability of the cells to
attach to GP140-coated surfaces. (c) Pro-a, and pro-a2 pro-
collagens and, to a lesser degree, GP 140 all bound fibronectin
and the gelatin-binding domain of fibronectin in both ligand
blot assays and affinity chromatography experiments (10). (d)
Immunofluorescence microscopy revealed extensive co-distri-
bution of fibronectin and GP140 in the matrix of confluent
fibroblasts. However, demonstration of co-distribution of
both proteins at molecular distances would require immuno-
electron microscopy.
The collagenlike nature of GP140 (9, 10) would obviously
suggest a direct interaction of fibronectin and GP140 via the
gelatin-binding domain of fibronectin (19). Results to be
presented elsewhere (11) have detected both immunological
and biochemical similarities of GP140 to the collagenous
peptide termed short-chain collagen or type VI (29, 30),
prepared by pepsin digestion of human placenta. The desig-
nation of short chain collagen (30) as a new type of collagen
(VI) was based on characterization of pepsin-resistant, colla-
genase-sensitive peptides of-60 kilodaltons in relative molec-
ular mass. Our own results (11) indicated that the pepsin-
resistant, collagenase-sensitive domain of GP140 is 64 kilo-
daltons. Thus, the noncollagenous domain of GP140 com-
prises over half of the native protein found in both extracel-
lular matrix and tissue (11). GP 140 may represent a hybrid
structure with characteristics of both collagens and other
extracellular matrix glycoproteins like fibronectin . These
unique hybrid qualities of GP140 may play a major role in
its assembly and interactions with various components of the
extracellular matrix.
Assembly of GP140 in the Extracellular Matrix
An analysis of the sequence of appearance of GP 140 and
fibronectin in the cytoplasm and matrix offibroblasts utilizing
both pulse-chase experiments and immunofluorescence mi-
croscopy yielded similar results by both techniques. Fibronec-
tin appeared in the matrix before GP140 with no prior accu-
mulation of an extensive cytoplasmic pool of fibronectin.
After accumulation of the cytoplasmic GP140, the matrix
GP140 appeared and co-localized with the already established
fibronectin matrix. These data strongly suggested that the
major matrix form of GP140 did not function as a receptor
for fibronectin. Rather, fibronectin may have functioned as a
receptor for GP140 either directly or through some interme-
diary component. Fibronectin may have provided a template
for the proper deposition of GP140 through noncovalent
interactions, followed by the intermolecular disulfide bonding
of matrix GP140. A number of reports (4, 5, 7, 31-33) have
indicated that type I and III collagens and/or procollagens
also co-distribute with fibronectin in the extracellular matrix .
Disulfide Bonding ofGP140 to Exogenous Matrix
The results presented in Fig. 8 indicated that normal cells
synthesized and covalently bound GP 140 into an exogenous
matrix. Most likely, GP140 disulfide bonded directly to ex-
ogenous GP 140 and not other matrix components in that, as
seen in Fig. 7, GP140 forms primarily homomultimers. This
bonding was dependent on cell contact with the exogenous
matrix. These experiments were unable to detect significant
levels ofreleased form GP140, that deposited in the exogenous
matrix. Conceivably, small quantities ofreleased GP 140 mayFIGURE 8 Disulfide bonding of GP140 to biotinylated exogenous matrix . Empigen BB-insoluble matrix of WI-38 cells was
prepared on divided culture plates (See Materials and Methods) . The two plates were reacted with and without N-hydroxysuc-
cinimidobiotin . One side of each divider plate was then seeded with WI-38 cells that had been metabolically labeled with [ 3 H]
glycine . Culture media, but not cells, had free passage across the plate divider. The plates were cultured for 2 d then extracted
with Empigen BB followed by 1 M urea in 1 M NaCl . The insoluble matrix from each side of the divider on both plates were then
solubilized with SDS (0.5% at 100°C) yielding four extracts (EXTRACTS) indicated 1, - biotin, - cells, + media ; 2, -biotin, + cells,
+ media ; 3, + biotin, - cells, + media ; and 4, + biotin, + cells, + media . Each extract was then incubated with or without avidin
(indicated + or - AVIDIN) to precipitate biotinylated matrix and any covalently bound radioactive components . All precipitates
were fractionated by polyacrylamide gel electrophoresis (7% gel) and detected by staining for protein with Coomassie Blue
(PROTEIN STAIN) and fluorography (FLUOROGRAPH) . Radioactive matrix components precipitated with avidin only from extract
4 (+ biotin, + cells, + media) . The precipitation of the radioactive matrix (as seen in FLUOROGRAPHY) but not the biotinylated
matrix (as seen in PROTEIN STAIN) could be inhibited with 2-mercaptoethanol (indicated as +2-ME) .
incorporate into the exogenous matrix . However, relative to
GP140 depositing directly from the cells, contributions from
the conditioned media are minor. In contrast to normal cells,
transformed cells lacked the ability to incorporate their own
GP140 into the exogenous matrix . Cells may stabilize their
association with extracellular matrix of adjacent cells by co-
valently bonding their own matrix components to the matrix
of adjacent cells. This disulfide-dependent cross-linking re-
quired direct cell contact or at least cell proximity to the
exogenous matrix .
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